Pengembangan dan validasi metode analisis siklofosfamid dan 4-hidroksisiklofosfamid dalam volumetric absorptive microsampling (VAMS) menggunakan KCKUT-SM/SM = Development and Validation of Cyclophosphamide and 4-hydroxycyclophosphamide quantification Method in volumetric absorptive microsampling (VAMS) by Liquid chromatography - tandem mass spectrometry
Steven;
Harahap, Yahdiana, supervisor; Herman Suryadi, supervisor; Berna Elya, examiner; Maggadani, Baitha Palanggatan, examiner; Eko Aditya Meinarno, examiner
(Fakultas Farmasi Universitas Indonesia, 2021)
|
|
Development and Validation of Cyclophosphamide and4-Hydroxycyclophosphamide Quantification Method inVolumetric Absorptive Microsampling (VAMS) by LiquidChromatography - Tandem Mass Spectrometry Cyclophosphamide is an anticancer alkylating prodrug, metabolized by CYP450 into its active metabolite, named 4-hydroxycyclophosphamide (4-OHCP). Its therapeutic effectiveness is determined by the 4-OHCP concentration. Several analytical methods using plasma and Dried Blood Spot have been developed to analyze cyclophosphamide and 4-OHCP. However, there are lots of disadvantages. Therefore, this study was conducted to develop a validated cyclophosphamide and 4-OHCP analysis method with 4-hydroxycyclophosphamide-d4 (4OHCP-d4) as the internal standard in Volumetric Absorptive Microsampling (VAMS) using Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry. VAMS requires small volume of sample, is not affected by hematocrit, and more efficient sampling process. Sample preparation was started by derivatization with 5 μL semicarbazide hydrochloride to overcome the instability of 4-OHCP and 4-OHCP-d4, which was absorbed by VAMS. Afterwards, 25 μL samples were absorbed into VAMS and extracted using the protein deposition method with methanol. The analysis was performed using a triple quadrupole Mass Spectrometry with positive electrospray ionization mode. The optimum conditions were obtained using the Acquity® UPLC BEH C18 column (2.1 x 100 mm; 1.7 μm); flow rate 0.2 mL/min; mobile phase 0.01% formic acid and methanol; gradient elution mode for 6 minutes; multiple reaction monitoring detection with m/z values 260.65>140.03 for cyclophosphamide, 333.65>221.04 for 4-OHCP-SCZ, and 337.71>225.05 for 4-OHCP-d4-SCZ. The method has met the validation requirements set by the FDA (2018). Cyclophosphamide LLOQ value was 5 ng/mL and the calibration curve range was 5 - 60,000 ng/mL. Furthermore, 4-OHCP LLOQ value was 2.5 ng/mL and the calibration curve range was 2.5 - 1,000 ng/mL. |
 S-Steven.pdf :: Unduh
|
| No. Panggil : | S-pdf |
| Entri utama-Nama orang : | |
| Entri tambahan-Nama orang : | |
| Entri tambahan-Nama badan : | |
| Subjek : | |
| Penerbitan : | Depok: Fakultas Farmasi Universitas Indonesia, 2021 |
| Program Studi : |
| Bahasa : | ind |
| Sumber Pengatalogan : | LibUI ind rda |
| Tipe Konten : | text |
| Tipe Media : | computer |
| Tipe Carrier : | online resource |
| Deskripsi Fisik : | xx,151 pages ; illustration |
| Naskah Ringkas : | |
| Lembaga Pemilik : | Universitas Indonesia |
| Lokasi : | Perpustakaan UI |
| No. Panggil | No. Barkod | Ketersediaan |
|---|---|---|
| S-pdf | 14-22-69069149 | TERSEDIA |
| Ulasan: |
| Tidak ada ulasan pada koleksi ini: 20516134 |
